Schumacher G E
Am J Hosp Pharm. 1975 Aug;32(8):639-42.
Potential pitfalls in evaluating bioavailibility data are presented. These pitfalls are involved with interpretation of the therapeutic significance of the data, the methodology of the bioavailibility study and presentation of data. Specific information which should be requested from manufacturers for proper evaluation of bioavailibility data is given.
文中介绍了评估生物利用度数据时可能存在的陷阱。这些陷阱涉及对数据治疗意义的解读、生物利用度研究的方法以及数据呈现。文中还给出了为正确评估生物利用度数据而应向制造商索取的具体信息。